T1	Participants 47 95	patients treated for a hematological malignancy.
T2	Participants 200 229	febrile neutropenic patients.
T3	Participants 246 281	patients with prolonged neutropenia
T4	Participants 590 711	the clinician's compliance with these rules in 1951 febrile neutropenic episodes was the subject of the present analysis.
